ADPT Total Utang marang Modal Adaptive Biotechnologies Inc.
Current price action for Adaptive Biotechnologies (ADPT) reflects a debt-to-equity ratio of 3.02. Adaptive Biotechnologies leads the field of immune analysis, attracting top geneticists and bioinformaticians through its innovative developments. A high barrier to entry is maintained by a robust patent portfolio and the complexity of certification. Business growth is driven by an alliance with a cloud behemoth and the joint development of tests with the largest pharmaceutical companies.
Rincian analitis lan laporan data perusahaan Adaptive Biotechnologies Inc. (ADPT)
- rega lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- data kapitalisasi buku:
- data utang lan likuiditas:
Utang marang Ekuitas Adaptive Biotechnologies|ADPT - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Adaptive Biotechnologies|ADPT - Gunggung utang perusahaan|Utang marang nilai buku Adaptive Biotechnologies|ADPT - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Adaptive Biotechnologies
Analisis komprehensif perusahaan:ADPT - Adaptive Biotechnologies Corporation
This ratio determines the proportion of borrowed funds relative to equity, where the current value of 3.02 reflects the degree of financial leverage and the risk of dependence on creditors. Analyzing the business's leverage ratio allows for an assessment of Adaptive Biotechnologies (ADPT) and its ability to finance costly FDA validation and AI developments without a critical debt burden, which is essential for maintaining stability within a stringent regulatory environment.
Pesaing utama
Utang marang Ekuitas argenx ARGX|Utang Agregat marang Ekuitas BioNTech Inc.|Abivax SA (ABVX) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi ADMA Corp (ADMA)|Total Utang marang Modal PTGX (Protagonist Therapeutics)|immunovant.com - Total Utang marang Modal|Utang marang Ekuitas Kiniksa (KNSA)|GRFS: Rasio Kabeh Utang marang Dana Pribadi|CLDX (Celldex) - Utang marang Ekuitas|Aurinia Corp (AUPH) - Rasio Total Utang marang Ekuitas|BCRX (BioCryst) - Total Utang marang Modal|Total Utang marang Modal veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Pharvaris NV (PHVS)|Total Utang marang Modal ABCL|Tourmaline - Koefisien Total Utang marang Modal|PGEN: Utang marang Ekuitas|PHAR: Rasio Total Utang marang Ekuitas|NKTR (Nektar Therapeutics Inc.) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal IMNM|Utang marang Ekuitas Gossamer Bio, Inc. GOSS|Rasio Utang marang Ekuitas kalvista.com (KALV)|SEPN: Total Utang marang Modal|Utang marang Modal Pieris Pharma PVLA|Savara Corp - Total Utang marang Modal|RIGL - Total Utang marang Modal|Total Utang marang Modal AnaptysBio, Inc.|astriatx.com (ATXS) - Rasio Utang marang Ekuitas|ENGN (enGene) - Total Utang marang Modal|Total Utang marang Modal RAPT|JBIO - Utang marang Ekuitas|Utang Agregat marang Ekuitas Aclaris Therapeutics, Inc ACRS|Rasio Total Utang marang Ekuitas Kyverna Therapeutics (KYTX)|Utang Agregat marang Modal tizianalifesciences.com TLSA|Total Utang marang Modal CABA (Cabaletta Bio)|Ventyx Biosciences Inc. (VTYX) - Koefisien Total Utang marang Modal|Theratechnologies Inc (THTX) - Rasio Total Utang marang Ekuitas|Avalo Therapeutics Inc (AVTX) - Utang marang Ekuitas|Total Utang marang Modal ELDN (Eledon Pharmaceuticals)|Utang marang Modal agenusbio.com (AGEN)|Climb Bio (CLYM) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Zura Bio Ltd (ZURA)|Total Utang marang Modal aTyr ATYR|Utang marang Ekuitas Adagene Inc ADAG|Total Utang marang Modal IMA (Ikena Oncology, Inc.)|STTK: Koefisien Total Utang marang Modal|Utang marang Ekuitas EQ|Utang marang Modal Connect Biopharma Holdings Limited|Immunic Therapeutics (IMUX) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal Atara Biotherapeutics Inc|InflaRx N.V. - Total Utang marang Modal|Utang marang Modal x4pharma.com (XFOR)|Adicet Bio, Inc. - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Celularity Inc CELU|Total Utang marang Modal INmune Bio Corp (INMB)|BRNS: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Kezar Life Sciences|SABS (sabbiotherapeutics.com) - Rasio Utang marang Ekuitas|Utang marang Ekuitas AKTX (Akari Therapeutics Plc)|Utang marang Modal ENLV|Utang marang Ekuitas Q32 Bio Inc. (QTTB)|Utang marang Ekuitas GOVX (GeoVax Corp)|EDSA: Utang marang Ekuitas|Utang marang Modal ibioinc.com IBIO|Total Utang marang Modal CARM|XTLB - Rasio Utang marang Modal|boltbio.com - Total Utang marang Modal|HCW Biologics (HCWB) - Koefisien Total Utang marang Modal|Total Utang marang Modal APVO (Aptevo Therapeutics, Inc.)|Utang marang Modal AIM|ADTX (Aditxt) - Utang marang Ekuitas|Koefisien Total Utang marang Modal GRI Bio Inc (GRI)|Total Utang marang Modal XRTX (XORTX)|Total Utang marang Modal Vyome Therapeutics HIND|Revelation Biosciences (REVB) - Total Utang marang Modal|INDP: Rasio Utang marang Ekuitas|Utang marang Ekuitas Scinai Immunotherapeutics Ltd. (SCNI)|Utang Agregat marang Ekuitas CalciMedica|Affimed NV (AFMD) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal ALLK|HOOK - Utang marang Ekuitas|Utang Agregat marang Ekuitas igmbio.com (IGMS)|Total Utang marang Modal iTeos Therapeutics, Inc.|Rasio Kabeh Utang marang Dana Pribadi Ocean Biomedical Inc OCEA|TC BioPharm (Holdings) PLC - Total Utang marang Modal|THRD: Total Utang marang Modal